AFM
GRNAW

Anson Funds Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Anson Funds Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-62,500
Closed -$618K – 406
2021
Q3 		$618K Hold
62,500
– – 0.06% 233
2021
Q2 		$613K Hold
62,500
– – 0.06% 233
2021
Q1 		$606K Buy
+62,500
New +$65.1K 0.07% 213

Other funds holding GRNAW

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Anson Funds Management's GRNAW Position: Q4 2021 in Review

Anson Funds Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q4 2021, closing a stake of 62,500 shares — an estimated $618K sold.

Anson Funds Management first reported a position in GRNAW in Q1 2021 and held it in 3 quarters. The position peaked at $618K in Q3 2021. 31 funds tracked by Wall St. Rank hold GRNAW as of Q4 2021.

  • Anson Funds Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q4 2021 after selling out during the quarter.
  • Anson Funds Management sold 62,500 GreenLight Biosciences Holdings, PBC Warrant shares in Q4 2021, an estimated $618K.
  • Anson Funds Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 3 quarters.
  • Anson Funds Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $618K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q4 2021.

Based on Anson Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.